Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival

Fang Wang(Loyola University Chicago), Wei Qiu(Loyola University Chicago)
Hepatology Communications
April 17, 2018
Cited by 24


Related Papers